Emcure Pharma launches weight loss drug Poviztra in India

Emcure Pharmaceuticals has launched Poviztra, a semaglutide injection for weight loss, becoming the first Indian company to exclusively distribute Novo Nordisk's medication. Available in a once-weekly pen device, Poviztra is indicated for chronic weight management in adults with obesity and at least one weight-related comorbidity.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VHFAsre
via IFTTT